Effects of Delayed School Start Times on Sleep, Mental Health, and Academic Performance Among Norwegian Adolescents
Launched by UNIVERSITY OF BERGEN · Oct 23, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how starting school later in the day can impact the sleep, mental health, and academic performance of high school students in Norway. Researchers want to see if giving students more time to sleep in the morning can lead to better overall well-being and improved focus during classes.
To participate in this study, students need to be in their first year of high school at one of the schools involved in the trial. It's important that parents give their permission for students under 16 years old to take part. If eligible, students will be part of a program that looks at how their sleep patterns and daily functioning change with later school start times. This trial aims to help understand if adjusting school schedules can benefit young people's health and learning.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1st year high school students at study preparatory program of participating schools
- Exclusion Criteria:
- • Parent consent not obtained/documented for participants under 16 years
About University Of Bergen
The University of Bergen is a renowned academic institution located in Norway, recognized for its commitment to advancing medical research and education. With a focus on interdisciplinary collaboration, the university engages in innovative clinical trials that aim to improve patient outcomes and enhance healthcare practices. Leveraging its diverse expertise and state-of-the-art facilities, the University of Bergen fosters a dynamic research environment that attracts both national and international partners, ensuring the translation of scientific discoveries into effective clinical applications. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bergen, Vestland, Norway
Patients applied
Trial Officials
Bjørn Bjorvatn
Principal Investigator
Department of Global Public Health and Primary Care, University of Bergen, Norway
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported